Drug
Elironrasib
Elironrasib: highest development phase Phase 1/2, developed by Revolution Medicines. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Revolution Medicines
Trials
| Drug | Phase | Indication |
|---|---|---|
| Elironrasib NCT06128551 | Phase 1/2 | Non-Small Cell Lung Cancer (NSCLC) |
Latest
No recent events.
Follow Elironrasib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.